3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Vulvar Neoplasms
1
Vulvar Diseases
1
Uterine Cervical Dysplasia
1
Recurrence
1
Peritoneal Neoplasms
1
Papillomavirus Infections
1
Ovarian Neoplasms
1
Ovarian Diseases
1
Neoplasms, Glandular and Epithelial
1
Neoplasms
1
Immunologic Deficiency Syndromes
1
Glioblastoma
1
Genital Neoplasms, Female
1
Fallopian Tube Neoplasms
1
Epstein-Barr Virus Infections
1
Cytomegalovirus Infections
1
Carcinoma, Transitional Cell
1
Carcinoma, Renal Cell
1
Carcinoma, Ovarian Epithelial
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma in Situ
1
Adenoviridae Infections
1
Abdominal Neoplasms
1
Interventions
Dexamethasone
239
Lenalidomide
145
daratumumab
123
Bortezomib
101
pomalidomide
86
Calcium Dobesilate
76
carfilzomib
74
Cyclophosphamide
70
Specimen Handling
42
isatuximab
40
Biopsy
40
fludarabine
36
belantamab mafodotin
36
Magnetic Resonance Spectroscopy
35
talquetamab
29
dexamethasone acetate
27
dexamethasone 21-phosphate
27
Melphalan
27
auricularum
26
iberdomide
25
ixazomib
22
fludarabine phosphate
22
selinexor
21
elotuzumab
21
Whole-Body Irradiation
14
X-Rays
13
tocilizumab
12
venetoclax
11
Mycophenolic Acid
10
trametinib
9
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Multiple Myeloma
×
Cell Count
×
1 year
×
Clear all
No trials found.